11 unknown. 11 Phase 2, 4 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Unknown 11 |
| Phase 1 | 4 | Unknown 4 |
| Phase 3 | 1 | Unknown 1 |
Follow Aplastic Anemia: new trials by email Literature Review of Aplastic Anemia trials Research Report on Aplastic Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard Immunosuppressive Therapy Combined With Romiplostim N01 as First-line Treatment for Severe Aplastic Anemia standard IST combined with Romiplostim N01 - Aplastic Anemia, TPO Receptor Agonists | Phase 2 | Unknown | Institute of Hematology & Blood Diseases Hospital, China | 48 | 2024-10-24 | 2024-12-04 |
| NAC for Hematopoietic Recovery in SAA N Acetyl L Cysteine - Aplastic Anemia | Phase 2 | Unknown | Peking University People's Hospital | 30 | 2024-07-25 | 2024-07-24 |
| Efficacy and Safety of CsA+AVA in the Treatment of NSAA in the Elderly Ciclosporin, Avatrombopag - Aplastic Anemia | Phase 2 | Unknown | Peking Union Medical College Hospital | 30 | 2023-08-17 | 2023-12-08 |
| GVHD Prophylaxis by Addition of CD20 Monoclonal Antibody to the Conditioning Regimen in SAA With Treatment of Allo-HSCT CD20 monoclonal antibody, ATG - Aplastic Anemia | Phase 2 | Unknown | The First Affiliated Hospital of Soochow University | 100 | 2021-12-30 | 2022-08-24 |
| Avatrombopag Usage in NSAA Avatrombopag 20 MG - Aplastic Anemia, Drug Effect | Phase 2 / Phase 3 | Unknown | Peking Union Medical College Hospital | 40 | 2021-02-01 | 2021-01-28 |
| Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination allogeneic donor derived B-lymphocytes - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | Unknown | University of Erlangen-Nürnberg Medical School | 15 | 2013-11-01 | 2014-03-26 |
| Mesenchymal Stem Cells Transplantation to Patients With Relapsed/Refractory Aplastic Anemia. bone marrow derived mesenchymal stem cells - Aplastic Anemia | Phase 1 / Phase 2 | Unknown | Guangzhou General Hospital of Guangzhou Military Command | 50 | 2011-02-01 | 2011-03-01 |
| Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Severe Aplastic Anemia Human umbilical cord-derived MSCs and cyclosporin A, cyclosporin A - Aplastic Anemia | Phase 2 | Unknown | Shandong University | 30 | 2010-08-01 | 2010-08-31 |
| Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA) Cyclophosphamide, Fludarabine, Thymoglobulin - Aplastic Anemia | Phase 2 | Unknown | The Korean Society of Pediatric Hematology Oncology | 33 | 2008-11-01 | 2012-03-26 |
| Study of Fludarabine + Cyclophosphamide + TBI Conditioning Regimen for Double Units Cord Blood Transplantation(CBT)in Severe Aplastic Anemia(SAA) Cyclophosphosphamide, TBI - Aplastic Anemia | Phase 1 / Phase 2 | Unknown | The Korean Society of Pediatric Hematology Oncology | 5 | 2008-11-01 | 2012-03-26 |
| Safety Study of CD3/CD19 Depleted Haploidentical Stem Cells Transplantation of CD3/CD19 depleted stem cells - Acute Leukemias, Aplastic Anemia | Phase 1 / Phase 2 | Unknown | University Children's Hospital Tuebingen | 120 | 2004-03-01 | 2014-10-08 |
Anemia, Aplastic (11) · Bone Marrow Diseases (1) · Brain Injuries, Traumatic (1) · Hodgkin Disease (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Non-Hodgkin (1) · Multiple Myeloma (1) · Myelodysplastic Syndromes (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Anemia (11) · Bone Marrow Failure Disorders (11) · Hematologic Diseases (11) · Hemic and Lymphatic Diseases (11) · Bone Marrow Diseases (10) · Blood Protein Disorders (1) · Brain Diseases (1) · Brain Injuries (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Chronic Disease (1) · Craniocerebral Trauma (1) · Disease Attributes (1) · Hemorrhagic Disorders (1) · Hemostatic Disorders (1)
Cyclosporine (2) · avatrombopag (2) · 188Re-anti-CD20 monoclonal antibody (1) · Acetylcysteine (1) · Cyclophosphamide (1) · Whole-Body Irradiation (1) · fludarabine (1) · thymoglobulin (1)
Peking Union Medical College Hospital (2) · The Korean Society of Pediatric Hematology Oncology (2) · Guangzhou General Hospital of Guangzhou Military Command (1) · Institute of Hematology & Blood Diseases Hospital, China (1) · Peking University People's Hospital (1) · Shandong University (1) · The First Affiliated Hospital of Soochow University (1) · University Children's Hospital Tuebingen (1) · University of Erlangen-Nürnberg Medical School (1)
China (6) · Germany (2) · South Korea (2) · Austria (1)
Hyo Seop Ahn, M.D, Ph.D (1) · Julia Winkler, MD (1) · Jun Shi, PhD (1) · Peter Lang, MD (1) · Yang Xiao, MD (1)